News & Media

Biocompare - BillionToOne to Offer Sanger Sequencing Based COVID-19 Test

APR 14 / 2020

BillionToOne anuncia innovadora prueba COVID-19 con capacidad para más de 1 millón de pruebas diarias

APR 14 / 2020

Coronavírus: empresa anuncia tecnologia capaz de realizar mais de 1 milhão de testes diários

APR 14 / 2020

新型コロナウイルス感染症の検査能力を「待機状態の検査機器」を使って大幅に引き上げる新たな手法が登場

APR 14 / 2020

New Coronavirus Protocol To Unlock A Million Daily Tests

APR 13 / 2020

A new approach to testing for COVID-19 could be just on the horizon.

APR 13 / 2020

"Nossa missão aqui na BillionToOne é eliminar o medo do desconhecido, disponibilizando diagnósticos moleculares poderosos para todos. Acreditamos que nosso teste COVID-19 pode ajudar bastante a eliminar as incógnitas na resposta à crise do COVID-19" afirmou o Dr. Oguzhan.

APR 11 / 2020

BillionToOne anuncia innovadora prueba

APR 11 / 2020

Notimex - Billiontoone anuncia test de COvid-19

APR 11 / 2020

A BillionToOne, companhia de diagnósticos de precisão, já disponibilizou o ensaio de teste exclusivo da empresa, que facilitará mais de 1 milhão de testes COVID-19

APR 11 / 2020

BillionToOne ile günde 1 milyon Covid-19 testi

APR 11 / 2020

Sanger sequencing-based COVID-19 test to be developed by BillionToOne

APR 11 / 2020

BillionToOne Goes Beyond qPCR with Sanger-Based COVID-19 Test

APR 11 / 2020

A Highly Scalable and Rapidly Deployable RNA Extraction-Free COVID-19 Assay by Quantitative Sanger Sequencing

APR 11 / 2020

New COVID19 Test Unlocking One Million Daily Tests

APR 11 / 2020

BillionToOne Developing Coronavirus Dx Test Based on Sanger Sequencing

APR 8 / 2020

BillionToOne Announces Groundbreaking New COVID-19 Test Unlocking One Million Daily Tests

APR 7 / 2020

Yahoo! Finance BillionToOne Announces Groundbreaking New COVID-19 Test Unlocking One Million Daily Tests

APR 7 / 2020

How Y Combinator Is Helping Combat COVID-19

MAR 27 / 2020

Y Combinator targets COVID-19 startups, pledges fast-tracked funding

MAR 25 / 2020

BillionToOne, Inc Response to COVID-19

MAR 17 / 2020

BillionToOne closes its follow-on Series A+ funding round of $15 million

MAR 10 / 2020

In the News: BillionToOne Closes $15M in Series A Follow-on Round

MAR 10 / 2020

BillionToOne to present series of single-gene NIPT posters at 2020 ACMG Annual Clinical Genetics Meeting

FEB 26 / 2020

BillionToOne to present a novel method to quantify the abundance of nucleic acid species at 20th AGBT Conference

JAN 22 / 2020

BillionToOne to present single-gene NIPT poster at 40th SMFM conference

JAN 3 / 2020

A Conversation with Dr. Oguzhan Atay, CEO BillionToOne, Inc

NOV 14 / 2019

Prenatal Blood Test for SMA Now Available in Four Countries in Europe, BillionToOne Announces

NOV 12 / 2019

Cystic Fibrosis Gene Test: "How much knowledge does a mother tolerate?" (German Article)

OCT 31 / 2019

BillionToOne, Inc. and Eluthia Launch UNITY™ Test, the First Non-Invasive Prenatal Test for Cystic Fibrosis, Spinal Muscular Atrophy and Hemoglobinopathies in Germany, Austria, Switzerland and the Netherlands

OCT 31 / 2019

BillionToOne Taps Eluthia as Exclusive Distributor of NIPT in Certain European Countries

OCT 31 / 2019

UNITY Prenatal Test Uses Maternal Blood to Effectively Screen for SCD, Other Genetic Disorders, Study Says

OCT 15 / 2019

UNITY Prenatal Blood Test Accurate at Diagnosing CF, Other Hereditary Diseases, Study Shows

OCT 14 / 2019

New prenatal blood test for single-gene diseases is launched (German Article)

OCT 8 / 2019

BillionToOne Publishes UNITY™ Validation Study in Nature Group's Scientific Reports

OCT 8 / 2019

Prenatal Blood Test for SMA and Other Single-Gene Diseases Now Available, BillionToOne Announces

JUL 15 / 2019

Newcomer BillionToOne launches prenatal blood screener for cystic fibrosis, SMA and sickle cell

JUL 1 / 2019

BillionToOne launches UNITY™ prenatal screen

JUN 27 / 2019

BillionToOne to Launch Noninvasive Prenatal Screening Test; Plans Liquid Biopsy Products

MAY 8 / 2019

BillionToOne Raises $15M in Series A Funding

MAR 31 / 2019